AIPT

Precision Therapeutics Inc. (AIPT)

Precision Therapeutics Inc.

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AIPT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2019/11/04	20 : 05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/30	19 : 20	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/28	21 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/26	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/25	06 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/17	05 : 39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/17	05 : 37	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/11	05 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 54	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/04	05 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/03	03 : 35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/02	07 : 35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/01	02 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/10/01	01 : 17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/27	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/27	06 : 16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/19	04 : 47	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/19	04 : 47	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/18	06 : 26	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/09/07	03 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/08/27	04 : 59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/08/20	06 : 25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/08/20	06 : 15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/08/16	06 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/08/15	06 : 11	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:AIPT	Precision Therapeutics Inc.
2019/07/29	23 : 09	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:AIPT	Precision Therapeutics Inc.